BioSpace News Archive

Business

Catalyst Biosciences Strengthens Clinical Hemophilia Programs With Additions to its Senior Leadership Team

The company appointed Arwa Shurrab as vice president of regulatory affairs and Jamie Ellen Siegel, M.D., as the head of clinical development.

November 28, 2017

·

4 min read

TESARO Announces U.S. FDA Approval of VARUBI IV fo

Policy

CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic

The IND acceptance results in a $10 million milestone payment to CytomX.

November 28, 2017

·

4 min read

BioMidwest

Philips Introduces Technology Maximizer to Boost Imaging Equipment Performance and Clinical Capabilities, and Help Manage Security Risk

Technology Maximizer provides confidence to radiology and cardiology department leaders and clinicians that their systems are up to date and compliant at a fraction of the cost of individual upgrades.

November 28, 2017

·

3 min read

Business

Skyline Medical and Helomics Announce a Joint Strategic Partnership With GLG Pharma

Companies to form a partnership for cell capture, culture and drug screening for ovarian and breast cancer patients.

November 28, 2017

·

8 min read

Astellas to Present New Data Exploring Gilteritinib in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients at the 2017 ASH

The wide selection of abstracts showcases the company’s full-scale development program across the FLT3 mutation-positive AML care continuum-from newly-diagnosed to relapsed or refractory patients.

November 28, 2017

·

6 min read

Business

Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement

Peregrine board reconstituted with four new independent directors.

November 28, 2017

·

6 min read

Drug Development

Athenex Announces Acceptance of Phase II Data of KX2-391 for the Treatment of Actinic Keratosis for Presentation at the American Academy of Dermatology Meeting on February 17, 2018

The abstract is entitled “Phase II Study of KX2-391 Ointment 1%, a Novel Field Treatment Based on Src/Tubulin Polymerization Inhibition, for Actinic Keratosis”.

November 28, 2017

·

3 min read

Policy

Agendia’s MammaPrint Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code

Agendia announces that its MammaPrint 70-Gene Breast Cancer Risk-of-Recurrence Test has received a favorable payment determination for CY 2018 from the CMS for its new CPT code.

November 28, 2017

·

2 min read

Drug Development

Zogenix To Host Call With Pediatric Epilepsy Expert Joseph Sullivan, M.D., on Dravet Syndrome and ZX008 on Monday, December 4

The company will host an update call on Dravet syndrome and the Company’s investigational drug, ZX008, featuring pediatric epilepsy expert, Joseph Sullivan, M.D., on Monday, December 4, 2017, at 4:30pm Eastern Time.

November 28, 2017

·

2 min read

Business

PositiveID Projects Revenue Growth of More Than 30% Year-Over-Year Through First Quarter of 2018

While the Company’s backlog typically is recognized over a six-month period following booking, management believes this strength portends well for continued growth throughout 2018.

November 28, 2017

·

5 min read